Acute Ischemic Stroke in Children - Should We Thrombolyze?

Area of Science:

• Pediatric Neurology
• Emergency Medicine
• Thrombotic Stroke Management

Background:

• Ischemic stroke in children causes acute neurological symptoms and long-term sequelae.
• Pediatric stroke presentation is heterogeneous, complicating diagnosis and mimicking other conditions.
• Acute thrombolysis is rarely used in children due to diagnostic challenges and lack of age-specific data.

Purpose of the Study:

• To review the current status of acute ischemic stroke management in children.
• To emphasize the role and challenges of thrombolytic therapy in pediatric stroke.
• To highlight the need for evidence-based guidelines and institutional pathways.

Main Methods:

• Critical review of existing literature on acute ischemic stroke management in children.
• Focus on case reports and limited trials regarding thrombolytic therapy (e.g., tPA).
• Analysis of barriers to guideline development and clinical trial implementation.

Main Results:

• Case reports suggest positive outcomes with timely intravenous thrombolysis using tPA in children.
• Endovascular interventions are also emerging as treatment options.
• Lack of large-scale, pediatric-specific clinical trials and safety data hinders guideline creation.

Conclusions:

• Despite promising case reports, robust clinical trials (RCTs) for pediatric stroke thrombolysis are absent.
• The premature termination of the TIPS trial underscores enrollment challenges.
• Developing institutional pathways is crucial for providing timely thrombolysis to eligible children until evidence-based guidelines are established.